Kevin A. Schulman

Duke University - Medical Center

100 Fuqua Drive

Durham, NC 27715

United States

SCHOLARLY PAPERS

8

DOWNLOADS
Rank 37,775

SSRN RANKINGS

Top 37,775

in Total Papers Downloads

1,159

SSRN CITATIONS
Rank 47,311

SSRN RANKINGS

Top 47,311

in Total Papers Citations

0

CROSSREF CITATIONS

10

Scholarly Papers (8)

1.

Entry and Competition in Generic Biologics

Managerial and Decision Economics, 2007
Number of pages: 39 Posted: 17 Jul 2007 Last Revised: 20 Sep 2014
Henry G. Grabowski, David B. Ridley and Kevin A. Schulman
Duke University - Department of Economics, Duke University - Fuqua School of Business and Duke University - Medical Center
Downloads 468 (60,768)

Abstract:

Loading...

generic, biologic, biological

2.

Lessons from India in Organizational Innovation: A Tale of Two Heart Hospitals

Health Affairs, Vol. 27, No. 5, 2008, Duke Law School Public Law & Legal Theory Paper No. 222, Duke Science, Technology & Innovation Paper No. 30
Number of pages: 13 Posted: 06 Oct 2008
Duke University - School of Law, affiliation not provided to SSRN, Duke University - Fuqua School of Business and Duke University - Medical Center
Downloads 241 (127,988)

Abstract:

Loading...

3.

A Novel Look at Antitrust Analysis in Health Insurance Markets

Competition Policy International, 2017, Duke Law School Public Law & Legal Theory Series No. 2017-51
Number of pages: 7 Posted: 25 Jul 2017
Barak D. Richman and Kevin A. Schulman
Duke University - School of Law and Duke University - Medical Center
Downloads 175 (172,909)

Abstract:

Loading...

health insurance mergers, architectural innovation, antitrust policy

4.

Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition

Rotman School of Management Working Paper No. 2977703, Loyola University Chicago Law Journal, Vol. 48, 2017, Duke Law School Public Law & Legal Theory Series No. 2017-43
Number of pages: 33 Posted: 01 Jun 2017
Barak D. Richman, Will Mitchell, Elena Vidal and Kevin A. Schulman
Duke University - School of Law, Duke University - Fuqua School of Business, City University of NY, Baruch College, Zicklin School of Business and Duke University - Medical Center
Downloads 136 (213,620)

Abstract:

Loading...

Pharmaceutical M&A, Pharmaceutical Innovation, Drug Prices

5.

Overbilling and Informed Financial Consent -- A Contractual Solution

New England Journal of Medicine, Vol. 476, No. 5, p. 396, August 2012
Number of pages: 2 Posted: 09 Aug 2012
Barak D. Richman, Mark A. Hall and Kevin A. Schulman
Duke University - School of Law, Wake Forest University - School of Law and Duke University - Medical Center
Downloads 96 (274,743)

Abstract:

Loading...

6.

A Cautious Path Forward on Accountable Care Organizations

Journal of the American Medical Association, Vol. 305, No. 6, February 2011
Number of pages: 2 Posted: 19 Oct 2012
Barak D. Richman and Kevin A. Schulman
Duke University - School of Law and Duke University - Medical Center
Downloads 43 (416,603)

Abstract:

Loading...

7.

Reassessing ACOs and Health Care Reform

Journal of the American Medical Association, Vol. 316, No.7, p. 707-708, August 2016
Posted: 17 May 2017
Kevin A. Schulman and Barak D. Richman
Duke University - Medical Center and Duke University - School of Law

Abstract:

Loading...

Accountable Care Organizations, Provider Market Power, Health Care Costs

8.

Battling the Chargemaster: A Simple Remedy to Balance Billing for Unavoidable Out-Of-Network Care

American Journal of Managed Care, Vol. 23, No. 4, 2017
Posted: 16 May 2017
Duke University - School of Law, Independent, Independent and Duke University - Medical Center

Abstract:

Loading...

Surprise Bills, Chargemaster, Narrow Networks